Looking for a way to improve the limit of detection for low-frequency CNVs and mutations?

Explore NuProbe’s technologies for liquid biopsies in oncology translational research and development at the 7th Annual Liquid Biopsy for Precision Oncology Summit, in San Diego, CA – proprietary technologies to enable ultrasensitive detection while overcoming the challenges of current methods.

Emerging Solutions for Non-Invasive Cancer Monitoring

Track A: Early Translation | February 15, 2023, at 12:30 PM PT

In this presentation, we will discuss the current state, advantages, and limitations of non-invasive liquid biopsies in oncology, and introduce Blocker Displacement Amplification (BDA), a rare allele enrichment technology with the potential to improve mutation detection from liquid biopsy. The presentation will highlight research applications of BDA in non-invasive longitudinal monitoring.


Nick Gallerani, Ph.D.
In his current role, Nicholas Gallerani, Ph.D., focuses on scientific communication and collaboration related to the applications and performance of NuProbe’s molecular technologies. Prior to joining NuProbe, he was a Fellow at Columbia Technology Ventures, where he assessed new technologies generated by Columbia University research labs. Nick received his Ph.D. in Pathobiology and Molecular Medicine from Columbia University and has co-authored four scientific publications.